Janssen Pharmaceutica

Global Analytical Development, Johnson Johnson Pharmaceutical Research and Development, A Division of Janssen Pharmaceutica n.v., Turnhoutseweg 30, B-2340 Beerse, Belgium C.H. Lochmuller... 

FDA. (2000) Janssen Pharmaceutica stops marketing cisapride in the US. in FDA Talk Paper, FDA, Rockville, MD. 

Analytical Development R D, Johnson Johnson Pharmaceutical Research Development, A division of Janssen Pharmaceutica NV, Turnhoutseweg 30,... 

Lores Laboratories GlaxoSmithKline Janssen Pharmaceutica Otsuka... 

Speakers Bureau Abbott Laboratories GlaxoSmithKline Janssen Pharmaceutica Pfizer Pharmaceuticals... 

One of the earliest forays into the development of designer drugs was the mid-1970s production of analogs of the legal drug fentanyl. Fentanyl was first synthesized in 1960 at the Belgian pharmaceutical firm of Janssen Pharmaceutica and first made commercially... 

Division of Janssen Pharmaceutica NV, 2340 Beerse, Belgium ptenholt prdbe.jnj.com Dept. of Oncology,... 

The authors gratefully acknowledge the suggestions and input of Dr. P. Buijnsters (Janssen Pharmaceutica, Beerse), Prof. P. Matyus (Semmelweis University, Budapest) and Dr. T. Stevenson (DuPont Crop Protection, Newark) for Sections 8.01.12.3 and 8.01.12.4. 

Recently, Janssen Pharmaceutica launched several studies of risperidone in children with borderline IQ or MR and a diagnosis of disruptive behavior disorder (usually oppositional defiant disorder or conduct disorder). To be admissible into the study, subjects needed to be 5 to 12 years old, inclusive, and score above 24 on the Conduct Problem subscale of the Nisonger Child Behavior Rating Form (NCBRF). One 6-week acute trial (n = 118) was conducted in the United States (Aman et al., in press), whereas the other n = 110) was based in Canada (Snyder et al., in press). The findings of the two studies were virtually identical, with... 

Meert, T. F. and van Belle, H. (Janssen Pharmaceutica) Use of draflazine-analogues for treating pain, W09857643. 

---